The quest to satisfy the sweet tooth without adding to the waistline has a new weapon in its arsenal: a strain of yeast that can metabolize lactose, the sugar in dairy products, into tagatose, a natural sweetener with less than half the calories of table sugar. The researchers published their work in the journal Nature Communications.
"Tagatose is a sweetener that exhibits almost identical tastes and textures of sucrose, or table sugar. However, tagatose has many fewer calories than sucrose - about 40% of sucrose," the author said. "In addition, it does not increase blood glucose levels as much as sucrose or fructose. The glycemic index of tagatose is 3, which is much lower than that of sucrose, 68, and fructose, 24. As such, tagatose carries a lower risk for developing Type 2 diabetes and other diseases caused by rapid and repeating glucose increases in blood."
In spite of its benefits, tagatose has a high manufacturing cost that has kept it from wide commercial use. Although it is naturally present in fruits and dairy products, the concentrations are too low to isolate tagatose effectively. The traditional manufacturing method involves a multi-step enzymatic process that turns galactose - a component of lactose - into tagatose.
Unfortunately, the enzyme reaction is so inefficient that only 30 percent of galactose is converted into tagatose, forcing manufacturers to use an expensive process to remove the tagatose from the galactose mixture.
The team used the internal machinery of yeast cells as tiny tagatose factories, much like how ethanol manufacturers use yeast to produce fuel from corn. The researchers engineered a strain of yeast that produces tagatose from lactose by making two genetic tweaks. First, they took out a gene (galactose kinase) that let the yeast use galactose as cellular fuel during lactose metabolism. Second, they added two genes (xylose reductase (XR) and galactitol dehydrogenase (GDH)) to convert galactose into tagatose. Then, the expression levels of XR and GDH were adjusted to maximize tagatose production.
Thus, when the yeast is fed lactose, its own metabolism drives it to produce a solution that is 90 percent tagatose - much higher than the 30 percent yield from traditional manufacturing. Yeast reactors also operate on much larger scales than enzyme-based ones, which could allow for efficient mass production of tagatose, the author said.
"Another advantage is that our yeast-based process can use whey indirectly. Whey is an inevitable byproduct of the cheese and Greek yogurt manufacturing processes as a raw material," the author said. "Due to the recent popularity of Greek yogurt, the disposal of whey is an issue in the dairy industry. We hope our process can be used to resolve the surplus whey problem. As our yeast fermentation-based approach allows a higher product ratio and the direct use of inexpensive dairy waste, we expect that the production cost of tagatose can be significantly reduced."
Next, the researchers will explore using their yeast-based approach to manufacture other products from lactose.
"We showed that lactose can be efficiently and rapidly utilized by engineered yeast. With further metabolic engineering, we can produce other valuable products from the lactose abundant in whey, using our engineered yeast strain," the author said.
https://www.nature.com/articles/s41467-019-09288-6
Yeast modified to synthesize low-calorie sweetener derived from lactose
- 1,835 views
- Added
Edited
Latest News
Abusive drugs hijack natura…
By newseditor
Posted 23 Apr
Mechanism of action of the…
By newseditor
Posted 23 Apr
Role of fat in rare neurolo…
By newseditor
Posted 23 Apr
How protein synthesis in de…
By newseditor
Posted 22 Apr
Atlas of mRNA variants in d…
By newseditor
Posted 22 Apr
Other Top Stories
Ultrasound disruption of blood-brain barrier
Read more
Visualizing gene expression with MRI
Read more
Imaging retinal ganglion cells
Read more
A biosensor to detect tumors at early stages
Read more
First cell culture of live adult human neurons shows potential of b…
Read more
Protocols
A programmable targeted pro…
By newseditor
Posted 23 Apr
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Publications
Exploiting pancreatic cance…
By newseditor
Posted 23 Apr
Structure of antiviral drug…
By newseditor
Posted 23 Apr
Type-I-interferon-responsiv…
By newseditor
Posted 23 Apr
Selenium, diabetes, and the…
By newseditor
Posted 23 Apr
Long-term neuropsychologica…
By newseditor
Posted 23 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar